Foster Wheeler secures pharma contract

Foster Wheeler has been awarded an engineering, procurement and construction (EPC) contract for Phase 2 of Schering-Plough’s multi-product active pharmaceutical ingredient plant (MPP2) in Tuas, Singapore. The contract, which is valued at USD 150 million, will be executed jointly by Foster Wheeler’s pharmaceutical centres of excellence in Reading, UK and Singapore. The plant is a “smart cloneâ€? of the MPP1 (multi-product plant) project that Foster Wheeler is currently finishing for Schering-Plough, also in Singapore. The plant will produce the cholesterol-lowering agent, ZETIA (ezetimibe) Tablets. Foster Wheeler was awarded the contract based on the planned completion of MPP1.

Looking for more projects or tenders?
Subscribe to our Project Preview Newsletter

Previous articleTaipower’s contract
Next articleCompressor/vacuum pump fluids
Stainless Steel World is part of The KCI Media Group, a group of companies focused on building and sustaining global communities in the flow control industries. We publish news on a daily basis and connect business-to-business professionals through our online communities, publications, conferences and exhibitions.